New antibiotics offer hope for drug-resistant gonorrhoea

theguardian.com

New antibiotics have been approved to treat drug-resistant gonorrhoea, marking a significant advancement in combating the sexually transmitted infection. The US Food and Drug Administration approved zoliflodacin and gepotidacin, the first new treatments in decades, as global gonorrhoea cases surge and drug-resistant strains rise. These approvals come as the World Health Organization designates gonorrhoea a priority pathogen due to increasing antibiotic resistance and limited treatment options worldwide.


With a significance score of 5.6, this news ranks in the top 0.6% of today's 31072 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: